Work Here?
Overview
Vitabiotics is a British, independent, family-run company that makes health care supplements and vitamins. It develops science-backed, balanced formulations tailored to different life stages and dietary needs, including vegan, vegetarian, and gluten-free options, sold online and through partnerships with educational and medical institutions. Its approach combines decades of nutritional research with a direct-to-consumer model and occasional promotions like free UK delivery. The goal is to improve wellbeing by providing high-quality, evidence-based supplements accessible to individuals and families.
About Vitabiotics
Industries
Healthcare
Consumer Goods
Company Size
501-1,000
Company Stage
Acquired
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
1971
Get referred to Vitabiotics
See people who can refer or advise you
Simplify's Take
What believers are saying
- Bain Capital signed in July 2026, validating Vitabiotics’ £900 million franchise value.
- Houlihan Lokey says FY25 sales reached about £275 million.
- New Ultra Magnesium Gummies and Star Wars kids gummies extend shelf-space and households.
What critics are saying
- Bain’s July 2026 purchase still needs regulatory approval, delaying integration and incentives.
- NAFDAC’s March 2026 counterfeit alert for Feroglobin B12 shows brand-security exposure.
- Which’s vitamin testing history pressures claims, label accuracy, and retailer confidence.
What makes Vitabiotics unique
- Vitabiotics is the U.K.’s No.1 vitamin brand, sold in 70-plus markets.
- Its pregnancy, children’s, and women’s lines anchor category-specific brand power.
- Clinical nutrition heritage and twice-winning Queen’s Award status reinforce trust.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$0
Below
Industry Average
Funded Over
1 Rounds
Benefits
Health Insurance
Dental Insurance
Wellness Program
Training Programs
Parental Leave
Paid Vacation
Hybrid Work Options
Employee Discounts
Company Events
Paid Sick Leave
Company News
Bain Capital agrees to acquire Vitabiotics. 27th July 2026 Bain Capital has agreed to acquire British vitamin and supplements business Vitabiotics in a deal reportedly valuing the company at up to $900m. The transaction includes Vitabiotics' UK operations and much of the wider VB Group, including Meyer Organics in India and operations across Africa. No official consideration has been disclosed, and completion remains subject to regulatory approval and other customary conditions. Bain said there would be no immediate changes to day-to-day operations, with the UK remaining central to the company's brand, innovation and category leadership.
Bain Capital to acquire Vitabiotics in £900m deal. * July 27, 2026 * - 9:16 am Bain Capital has agreed to acquire British vitamins and supplements company Vitabiotics, in a transaction that values the business at approximately £900m, according to a report by Bloomberg citing unnamed people familiar with the matter. The deal will see Bain's Asian private equity team lead the investment in the wider Vitabiotics Group, which includes India-based Meyer Organics and operations in Africa, including VB Egypt. The parties have not disclosed financial terms. Vitabiotics markets a portfolio of supplement brands including Wellman, Wellwoman, Pregnacare and Wellbaby, with its products widely sold through pharmacies and other retailers in the UK. Chief executive Tej Lalvani, who previously appeared as an investor on the BBC television programme Dragons' Den, said the company had built its business by targeting specific consumer categories and developing market-leading positions in areas including pregnancy and children's nutrition. Lalvani, whose father Kartar Lalvani, founded the company in 1971, said consumer attitudes towards health and wellness had shifted significantly since the Covid-19 pandemic, with greater emphasis on quality of life, nutrition and lifestyle. The acquisition comes amid a wave of takeover activity involving UK companies, as international investors continue to target businesses with global operations. Lalvani said he hoped the UK government would recognise the importance of attracting investment and retaining wealth in the country. He has relocated to the United Arab Emirates but continues to visit the UK regularly. Bain Capital was advised by Rothschild & Co, while Houlihan Lokey advised Vitabiotics.
Bain Capital has signed final agreements to acquire 100% of British nutraceuticals firm Vitabiotics for over $1 billion, according to sources familiar with the matter. The company, founded by Indian-origin entrepreneur Dr Kartar Lalvani, operates in the UK, China, and India. Vitabiotics' portfolio includes brands such as Wellman and Wellwoman multivitamins, Perfectil for skin and hair care, Pregnacare pregnancy support, and Osteocare bone health supplements. The firm exports to over 100 countries and previously received the Queen's Award for Innovation. Discussions are underway to potentially onboard a co-investor alongside Bain Capital, though no final decision has been made. Neither Vitabiotics nor Bain Capital provided immediate comment on the transaction.
Vitabiotics launches Ultra(TM) Magnesium citrate gummies. * Vitabiotics has launched Ultra(TM) Magnesium Gummies, expanding the UK's No.1 Magnesium supplement brand* with a convenient gummy format * Each two-gummy serving provides 300mg magnesium in magnesium citrate form, along with 100% NRV (1.4mg) vitamin B6 * Developed as the latest innovation within the Ultra(TM) range, reflecting growing consumer interest in magnesium supplements and gummy formats Vitabiotics, the UK's No.1 vitamin company**, has introduced Ultra(TM) Magnesium Gummies, the newest addition to its Ultra(TM) range. The launch responds to rising consumer demand for magnesium supplements in different forms reflecting awareness of magnesium's role in supporting many areas of health and wellbeing including the nervous system, muscle function and to help reduce tiredness and fatigue. Gummies have exploded in popularity recently, across the wider vitamins and supplements market. Two gummies provide 300mg magnesium per daily serving, delivered in magnesium citrate form, along with 100% NRV (1.4mg) vitamin B6. Magnesium and vitamin B6 contribute to the reduction of tiredness and fatigue, normal energy release and normal psychological and nervous system functions, while magnesium also supports normal muscle function and the maintenance of normal bones and teeth. There is growing interest in different forms of magnesium. Magnesium citrate is a form of magnesium that is bound to citric acid. It is one of the most bioavailable forms, meaning it is easily and efficiently absorbed by the body. It's also generally well tolerated and is less likely to cause digestive discomfort. Ultra(TM) Magnesium Gummies are available in a delicious strawberry flavour, are vegan-friendly, and free from preservatives, artificial colours, and sweeteners. Each pack contains 60 gummies (2 per serving/30-day supply), with a RRP of £17.95. Melissa Cohen, Head of Nutrition at Vitabiotics, says: "Interest in magnesium continues to grow, with many consumers looking for formats that fit easily into daily routines. Magnesium plays an important role in the body, supporting normal muscle function, psychological function and energy release. By combining magnesium with vitamin B6 in a convenient gummy format, Ultra(TM) Magnesium Gummies offer a practical alternative to tablets and capsules. Taken daily, these nutrients contribute to normal energy release, muscle function and the reduction of tiredness and fatigue as part of a varied, balanced diet." Demand for magnesium Growing consumer awareness of the benefits of magnesium has contributed to increasing demand. Monthly search volumes for magnesium reached 3.3 million in 2024, an increase of over 480,000 from the previous year[1]. According to Mintel, 16% of UK adults who use vitamins and minerals include magnesium in their routine[2], reflecting its popularity among consumers looking to support everyday wellbeing. Ultra(TM) Magnesium is already established as the UK's No.1 Magnesium supplement brand* attributable to the popular tablets product. The launch of Ultra(TM) Magnesium Gummies provides consumers with a new way to enjoy magnesium in citrate form, in a chewable gummy format as part of the leading Ultra(TM) range. Key Product Information (2 per day): * Provides 300mg magnesium per daily serving in magnesium citrate form, along with 100% NRV (1.4mg) vitamin B6 * Magnesium + vitamin B6 contribute to the reduction of tiredness and fatigue, to normal psychological and nervous system function and to normal energy release * Magnesium contributes to normal muscle function, and the maintenance of normal bones and teeth * Suitable for vegans and vegetarians with a delicious strawberry flavour; free from preservatives, artificial colours and sweeteners * 60 gummies per pack; two gummies per day (with your meal) * RRP: £17.95 Ultra(TM) Magnesium Gummies are available at Vitabiotics.com and in-store at selected retailers. * Nielsen GB ScanTrack Total Coverage, Value Sales, 52 w/e 4th October 2025. ** Nielsen GB ScanTrack Value and Unit Sales, 52 w/e 4th October 2025. 1. NutraIngredients - Top supplement trends, according to Google (magnesium search volume). 2. Mintel - UK Vitamins and Supplements Market Report 2023 (magnesium usage among adults). 3. NutraIngredients - Gummy Vitamins Market Size, Share, Growth and Industry Analysis.uou
Vitabiotics has collaborated with Disney to launch new Wellkid Gummies with Star Wars The Mandalorian.
Vitabiotics is Hiring for 9 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Vitabiotics
Industries
Healthcare
Consumer Goods
Company Size
501-1,000
Company Stage
Acquired
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
1971
Vitabiotics is Hiring for 9 Jobs on Simplify!
Find jobs on Simplify and start your career today